Supplemental Information or Form
Form LAB 444 (03/12) (MDL-N-25), EXAMINATION FOR MYCOBACTERIUM TUBERCULOSIS DRUG SUSCEPTIBILITY
Performed on Specimens from
California local public health laboratories
Acceptable Sample/Specimen Type for Testing
Minimum Volume Required
Storage & Preservation of Specimen Prior to Shipping
Incubated at 35-37°C (or refrigerated).
Patient’s name, accession number, inoculation date or subculture date.
Shipping Instructions which Include Specimen Handling Requirements
Ship as infectious substance.
By MGIT 960. Drugs routinely tested are isoniazid (INH) 0.1 μg/ml, rifampin 1 µg/ml, ethambutol 5 µg/ml, and pyrazinamide 100 µg/ml. When there is resistance to rifampin, or to any two first line drugs, second line drug susceptibility testing is performed. When there is resistance to INH at a concentration of 0.1 μg/ml, testing at 0.4 μg/ml is performed.
7 to 14 days
Interferences & Limitations
Results unattainable because culture submitted is mixed with nother mycobacteria (usually Mycobacterium avium complex) or mixed with a non-mycobacteria contaminant.
MDL Points of Contact
Mycobacterial Diseases Section (drug susceptibilities) (510) 412-3929 Email: email@example.com
| Conditions of Use